Assignee
INFINITY PHARMACEUTICALS INC
US·76 granted patents·41 pending applications·611 citations·filing 2004–2024
Top patents by PatentIndex Score
117 records- 0199US7812164B2Cyclopamine analogsINFINITY PHARMACEUTICALS INC·Filed 2007·Granted Oct 12, 2010·84 cites·2 claims
- 0297US9181221B2Chemical compounds, compositions and methods for kinase modulationINFINITY PHARMACEUTICALS INC·Filed 2013·Granted Nov 10, 2015·64 cites·18 claims
- 0397US8017648B2Methods of use of cyclopamine analogsINFINITY PHARMACEUTICALS INC·Filed 2007·Granted Sep 13, 2011·37 cites·21 claims
- 0496US9359365B2Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2014·Granted Jun 7, 2016·24 cites·24 claims
- 0596US9238672B2Methods for stereoselective reductionINFINITY PHARMACEUTICALS INC·Filed 2014·Granted Jan 19, 2016·14 cites·24 claims
- 0696US8940742B2Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2013·Granted Jan 27, 2015·35 cites·48 claims
- 0796US7407967B2Cyclopamine analogues and methods of use thereofINFINITY PHARMACEUTICALS INC·Filed 2007·Granted Aug 5, 2008·52 cites·18 claims
- 0895US10406139B2Cyclopamine analogsINFINITY PHARMACEUTICALS INC·Filed 2018·Granted Sep 10, 2019·8 cites·5 claims
- 0995US9145422B2Methods of use of cyclopamine analogsINFINITY PHARMACEUTICALS INC·Filed 2013·Granted Sep 29, 2015·16 cites·30 claims
- 1095US9115141B2Substituted isoquinolinones and methods of treatment thereofINFINITY PHARMACEUTICALS INC·Filed 2013·Granted Aug 25, 2015·27 cites·49 claims
- 1194US9775844B2Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2015·Granted Oct 3, 2017·13 cites·48 claims
- 1294US9492435B2Cyclopamine analogsINFINITY PHARMACEUTICALS INC·Filed 2014·Granted Nov 15, 2016·13 cites·15 claims
- 1394US9255108B2Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2014·Granted Feb 9, 2016·21 cites·45 claims
- 1493US9708348B2Trisubstituted bicyclic heterocyclic compounds with kinase activities and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2015·Granted Jul 18, 2017·13 cites·21 claims
- 1592US10675286B2Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2017·Granted Jun 9, 2020·4 cites·19 claims
- 1692US10329299B2Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2017·Granted Jun 25, 2019·7 cites·26 claims
- 1792US9388183B2Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2014·Granted Jul 12, 2016·19 cites·26 claims
- 1891US11541059B2Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2020·Granted Jan 3, 2023·2 cites·11 claims
- 1991US10314827B2Methods of use of cyclopamine analogsINFINITY PHARMACEUTICALS INC·Filed 2018·Granted Jun 11, 2019·4 cites·11 claims
- 2091US10045970B2Methods of use of cyclopamine analogsINFINITY PHARMACEUTICALS INC·Filed 2017·Granted Aug 14, 2018·4 cites·9 claims
- 2191US7361647B2Analogs of benzoquinone-containing ansamycins and methods of use thereofINFINITY PHARMACEUTICALS INC·Filed 2005·Granted Apr 22, 2008·6 cites·45 claims
- 2291US7282493B2Analogs of benzoquinone-containing ansamycins and methods of use thereofINFINITY PHARMACEUTICALS INC·Filed 2004·Granted Oct 16, 2007·15 cites·146 claims
- 2390US11007181B2Cyclopamine analogsINFINITY PHARMACEUTICALS INC·Filed 2019·Granted May 18, 2021·1 cites·2 claims
- 2490US10821102B2Methods of use of cyclopamine analogsINFINITY PHARMACEUTICALS INC·Filed 2019·Granted Nov 3, 2020·1 cites·11 claims
- 2590US9951083B2Cyclopamine analogsINFINITY PHARMACEUTICALS INC·Filed 2016·Granted Apr 24, 2018·4 cites·19 claims
- 2690US9879025B2Transfer hydrogenation of cyclopamine analogsINFINITY PHARMACEUTICALS INC·Filed 2016·Granted Jan 30, 2018·3 cites·13 claims
- 2790US9669011B2Methods of use of cyclopamine analogsINFINITY PHARMACEUTICALS INC·Filed 2015·Granted Jun 6, 2017·4 cites·13 claims
- 2890US9527847B2Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitorsINFINITY PHARMACEUTICALS INC·Filed 2014·Granted Dec 27, 2016·12 cites·35 claims
- 2990US7375217B2Analogs of benzoquinone-containing ansamycins and methods of use thereofINFINITY PHARMACEUTICALS INC·Filed 2005·Granted May 20, 2008·6 cites·20 claims
- 3089US8828998B2Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitorsINFINITY PHARMACEUTICALS INC·Filed 2013·Granted Sep 9, 2014·11 cites·48 claims
- 3189US7608613B2Analogs of benzoquinone-containing ansamycins and methods of use thereofINFINITY PHARMACEUTICALS INC·Filed 2008·Granted Oct 27, 2009·3 cites·25 claims
- 3288US11247995B2Solid forms of isoquinolinones, and process of making, composition comprising, and methods of using the sameINFINITY PHARMACEUTICALS INC·Filed 2018·Granted Feb 15, 2022·2 cites·44 claims
- 3388US7767663B2Analogs of benzoquinone-containing ansamycins and methods of use thereofINFINITY PHARMACEUTICALS INC·Filed 2009·Granted Aug 3, 2010·3 cites·50 claims
- 3487US9828377B2Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2015·Granted Nov 28, 2017·4 cites·43 claims
- 3587US7947663B2Inhibitors of fatty acid amide hydrolaseINFINITY PHARMACEUTICALS INC·Filed 2007·Granted May 24, 2011·6 cites·12 claims
- 3686US11147818B2Combination therapiesINFINITY PHARMACEUTICALS INC·Filed 2017·Granted Oct 19, 2021·2 cites·36 claims
- 3786US11110096B2Combination therapiesINFINITY PHARMACEUTICALS INC·Filed 2017·Granted Sep 7, 2021·3 cites·16 claims
- 3886US10759806B2Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as PI3K kinase inhibitorsINFINITY PHARMACEUTICALS INC·Filed 2017·Granted Sep 1, 2020·3 cites·22 claims
- 3986US9290497B2Processes for preparing isoquinolinones and solid forms of isoquinolinonesINFINITY PHARMACEUTICALS INC·Filed 2014·Granted Mar 22, 2016·6 cites·37 claims
- 4086US7842815B2Compounds and methods for inhibiting the interaction of BCL proteins with binding partnersINFINITY PHARMACEUTICALS INC·Filed 2006·Granted Nov 30, 2010·5 cites·3 claims
- 4186US2025197400A1Processes for preparing isoquinolinones and solid forms of isoquinolinonesINFINITY PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 4285US7851637B2Compounds and methods for inhibiting the interaction of BCL proteins with binding partnersINFINITY PHARMACEUTICALS INC·Filed 2005·Granted Dec 14, 2010·13 cites·17 claims
- 4383US11312718B2Formulations of (S)-3-(1-(9H-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1(2H)-oneINFINITY PHARMACEUTICALS INC·Filed 2020·Granted Apr 26, 2022·1 cites·34 claims
- 4483US9879293B2Enzymatic transamination of cyclopamine analogsINFINITY PHARMACEUTICALS INC·Filed 2016·Granted Jan 30, 2018·3 cites·30 claims
- 4582US9481667B2Salts and solid forms of isoquinolinones and composition comprising and methods of using the sameINFINITY PHARMACEUTICALS INC·Filed 2014·Granted Nov 1, 2016·4 cites·35 claims
- 4682US8349814B2Inhibitors of fatty acid amide hydrolaseINFINITY PHARMACEUTICALS INC·Filed 2011·Granted Jan 8, 2013·3 cites·17 claims
- 4782US8003634B2Analogs of benzoquinone-containing ansamycins and methods of use thereofINFINITY PHARMACEUTICALS INC·Filed 2010·Granted Aug 23, 2011·3 cites·33 claims
- 4882US7579337B2Analogs of benzoquinone-containing ansamycins and methods of use thereofINFINITY PHARMACEUTICALS INC·Filed 2008·Granted Aug 25, 2009·1 cites·18 claims
- 4982US2025319091A1Treatment of cancers using pi3 kinase isoform modulatorsINFINITY PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 5081US11939333B2Solid forms of isoquinolinones, and process of making, composition comprising, and methods of using the sameINFINITY PHARMACEUTICALS INC·Filed 2022·Granted Mar 26, 2024·0 cites·18 claims
Showing the top 50 of 117 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when INFINITY PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →